Growth Metrics

Privia Health (PRVA) Debt to Equity (2020 - 2022)

Privia Health's quarterly Debt to Equity came in at $0.07 in Q1 2022, down 68.17% year-on-year from $0.22 in Q1 2021, and down 2.25% quarter-over-quarter from $0.07 in Q4 2021.

Privia Health has reported Debt to Equity for 3 years, with the latest figure at $0.07 in Q1 2022.

  • For the quarter ending Q1 2022, Debt to Equity fell 68.17% year-over-year to $0.07; the trailing twelve-month figure through Mar 2022 stood at $0.07 (down 68.17% YoY), and the FY2021 full-year result was $0.07, down 69.16% from the prior year.
  • Debt to Equity for Q1 2022 stood at $0.07, down from $0.07 in the prior quarter.
  • The five-year high for Debt to Equity was $0.23 in Q4 2020, with the low at $0.07 in Q1 2022.
  • Average Debt to Equity over 3 years is $0.12, with a median of $0.08 recorded in 2021.
  • Year-over-year, Debt to Equity sank 69.16% in 2021 and slumped 68.17% in 2022.
  • Tracing PRVA's Debt to Equity over 3 years: stood at $0.23 in 2020, then slumped by 69.16% to $0.07 in 2021, then dropped by 2.25% to $0.07 in 2022.
  • The last three Debt to Equity figures came in at $0.07 (Q1 2022), $0.07 (Q4 2021), and $0.08 (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 1.26
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.46
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.37
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 0.07
Dec 31, 2021 0.07
Sep 30, 2021 0.08
Jun 30, 2021 0.08
Mar 31, 2021 0.22
Dec 31, 2020 0.23